SYK — STRYKER CORP

NYSE · Health Care · Health Care Equipment & Supplies · CIK 310764 ·
Last close
$347.21
Market Cap
$133.18B
52W High
$352.49
52W Low
$289.23
ADV30
2,383,208
Next earnings
2026-10-29
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026 6,589,000,000 4,498,000,000 1,660,000,000 1,276,000,000 47,930,000,000 3,391,000,000 23,942,000,000
Mar 2026 6,020,000,000 3,810,000,000 936,000,000 745,000,000 46,291,000,000 2,878,000,000 23,312,000,000
Dec 2025 7,171,000,000 4,628,000,000 1,811,000,000 849,000,000 47,844,000,000 4,011,000,000 25,424,000,000
Sep 2025 6,057,000,000 3,852,000,000 1,208,000,000 859,000,000 47,057,000,000 3,256,000,000 25,272,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$5,375,000,000
Investing CF
$-915,000,000
Financing CF
$-3,931,000,000
CapEx
$-804,000,000
Dividends Paid
$-1,301,000,000
Buybacks
EPS Diluted TTM
$8.64
As of
2026-08-02

Balance + Analyst (yfinance extras)

Retained Earnings
$20,878,000,000
Inventory
$5,419,000,000
Receivables
$3,571,000,000
ST Investments
$87,000,000
EBIT TTM
$5,247,000,000
Pretax Income TTM
$4,600,000,000
Interest Exp TTM
$285,000,000
Analysts
26

Yahoo Snapshot (yfinance, live)

Total Revenue
$25,837,000,704
EBITDA
$7,376,000,000
Free Cash Flow
$4,107,624,960
Enterprise Value
$145,150,394,368
Total Cash
$3,476,000,000
Total Debt
$15,445,999,616
Shares Out
383,573,046
Trailing EPS
$9.62
Book Value
$59.94
ROE
16.5%
ROA
8.2%
Div Yield
1.01%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 25,116,000,000 5,059,000,000 3,246,000,000 47,844,000,000 25,424,000,000 5,044,000,000
Dec 2024 22,595,000,000 4,666,000,000 2,993,000,000 42,971,000,000 22,337,000,000 4,242,000,000
Dec 2023 20,498,000,000 3,924,000,000 3,165,000,000 39,912,000,000 21,319,000,000 3,711,000,000
Dec 2022 18,449,000,000 3,111,000,000 2,358,000,000 36,884,000,000 20,268,000,000 2,624,000,000

TTM Snapshot

Revenues TTM
$19,042,000,000
NetIncome TTM
$2,780,000,000
OpCashFlow TTM
$0
Assets (Latest)
$42,971,000,000
Forward EPS
$16.76

Max Pain — expiry 2026-08-21

max pain strike: $330.00 · spot: $341.09 · call oi: 5,461 · put oi: 2,042
Expected Move to 2026-08-21: ±$10.95 (3.21%) — implied range $330.14$352.04 · ATM straddle on $340.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ISRG INTUITIVE SURGICAL INC $143.77B $401.27
MDT Medtronic plc $116.18B $90.76
MMM 3M CO $94.78B $183.78
BSX BOSTON SCIENTIFIC CORP $74.52B $51.42
EW Edwards Lifesciences Corp $53.58B $93.05

News headlines (Yahoo Finance, 1h cache)

Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?
2026-08-13 17:49 · Yahoo
Is SYK Worth Buying as Growth Improves but Execution Risks Persist?
2026-08-13 17:49 · Yahoo
Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
2026-08-13 17:49 · Yahoo
Priori Expands Client Advisory Board with New Members from Fortune 500 Corporate Legal Departments
2026-08-13 13:00 · Yahoo
Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
2026-08-13 12:37 · Yahoo
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More
2026-08-13 11:53 · Yahoo
The Paid-To-Hold Play On ISRG Stock: A 12% Annualized Income
2026-08-12 21:37 · Yahoo
Two Years Of Growth Barely Change What You Pay For Intuitive Surgical
2026-08-12 17:20 · Yahoo
PBH or SYK: Which Is the Better Value Stock Right Now?
2026-08-12 15:40 · Yahoo
Medtronic veteran departs for CEO role at heart valve startup
2026-08-12 10:58 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.